SKI Market

Indian Indices

Sensex

82,344.68 487.20
( 0.60%)

Global Indices

Nasdaq

49,020.90 -412.51
(-0.83%)

Dow Jones

6,999.25 28.02
(0.40%)

Hang Seng

53,273.44 -60.10
(-0.11%)

Nikkei 225

10,215.77 66.92
(0.66%)

Forex

USD-INR

91.65 0.01
(0.01%)

EUR-INR

108.74 0.34
(0.32%)

GBP-INR

125.29 0.27
(0.21%)

JPY-INR

0.59 0.01
(1.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

189.38

42.27

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

srs ltd

GE Vernova T&D India standalone net profit rises 107.08% in the September 2025 quarter

Nov 03,2025

Net profit of GE Vernova T&D India rose 107.08% to Rs 299.48 crore in the quarter ended September 2025 as against Rs 144.62 crore during the previous quarter ended September 2024. Sales rose 38.88% to Rs 1538.46 crore in the quarter ended September 2025 as against Rs 1107.77 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1538.46	1107.77	39
OPM %	25.77	18.48	-
PBDT	412.88	205.80	101
PBT	401.27	193.75	107
NP	299.48	144.62	107

82,344.68 487.20 ( 0.60%)

49,020.90 -412.51 (-0.83%)

6,999.25 28.02 (0.40%)

53,273.44 -60.10 (-0.11%)

10,215.77 66.92 (0.66%)

91.65 0.01 (0.01%)

108.74 0.34 (0.32%)

125.29 0.27 (0.21%)

0.59 0.01 (1.05%)